开放肺策略在急性呼吸窘迫综合征管理中的应用:系统评价与Meta分析
该研究为系统评价与Meta分析,检索PubMed、Embase、Web of Science和Cochrane Central Register of Controlled Trials至2016年5月22日,纳入15项随机对照试验,共1563例开放肺策略组和1571例对照组患者。主要终点为死亡率。汇总分析显示开放肺策略组住院死亡率(RR 0.88,95%CI 0.80-0.97,P=0.009)、28天死亡率(RR 0.83,95%CI 0.71-0.96,P=0.010)和ICU死亡率(RR 0.77,95%CI 0.65-0.92,P=0.003)均显著低于对照组,异质性无实质性。28天无呼吸机天数(MD 3.32天,95%CI -0.49至7.12,P=0.09)和ICU住院时长(MD 1.60天,95%CI -2.99至6.20,P=0.49)两组无显著差异。结论提示机械通气期间开放肺策略可显著降低ARDS患者死亡率。
要点
- 开放肺策略组住院死亡率显著低于对照组(RR 0.88,95%CI 0.80-0.97,P=0.009)。
- 开放肺策略组28天死亡率显著低于对照组(RR 0.83,95%CI 0.71-0.96,P=0.010)。
- 开放肺策略组ICU死亡率显著低于对照组(RR 0.77,95%CI 0.65-0.92,P=0.003)。
- 28天无呼吸机天数两组无显著差异(MD 3.32天,95%CI -0.49至7.12,P=0.09)。
- ICU住院时长两组无显著差异(MD 1.60天,95%CI -2.99至6.20,P=0.49)。
适用人群与场景
- 急性呼吸窘迫综合征(ARDS)患者,纳入15项随机对照试验中接受机械通气者。
处置流程与药物剂量
- 开放肺策略包括机械通气期间应用呼气末正压和肺复张操作。
研究设计与关键结果
- 研究类型为系统评价与Meta分析,纳入15项随机对照试验,开放肺策略组1563例、对照组1571例ARDS患者。
- 主要终点住院死亡率:开放肺策略组 vs 对照组 RR 0.88(95%CI 0.80-0.97,P=0.009),开放肺策略组显著降低。
- 28天死亡率:RR 0.83(95%CI 0.71-0.96,P=0.010),开放肺策略组显著降低。
- ICU死亡率:RR 0.77(95%CI 0.65-0.92,P=0.003),开放肺策略组显著降低。
- 28天无呼吸机天数:MD 3.32天(95%CI -0.49至7.12,P=0.09),两组无显著差异。
- ICU住院时长:MD 1.60天(95%CI -2.99至6.20,P=0.49),两组无显著差异。
证据类型、等级与局限
- 证据类型为系统评价与Meta分析,纳入15项随机对照试验。
- 汇总分析显示异质性无实质性。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,机械通气期间开放肺策略可显著降低ARDS患者死亡率。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: An open lung strategy (OLS) that includes positive end expiratory pressure and recruitment maneuvers during mechanical ventilation is probably an important treatment method in patients with acute respiratory distress syndrome (ARDS). However, the effect of OLS is unknown. We therefore hypothesized that patients with ARDS may benefit from OLS treatment.
METHODS: We identified relevant randomized controlled trials by searching through PubMed, Embase, Web of Science, and the Cochrane Central Register of Controlled Trials updated to May 22, 2016. We performed a systematic review and meta-analysis to evaluate the effect of OLS in patients with ARDS. The primary outcome was mortality.
RESULTS: A total of 15 randomized controlled trials involving 1,563 patients in OLS group and 1,571 patients in control group were included. Pooled analysis showed that there was significant difference in hospital mortality (relative risk [RR], 0.88; 95% CI, 0.80-0.97; P = 0.009), 28-day mortality (RR, 0.83; 95% CI, 0.71-0.96; P = 0.010), and intensive care unit (ICU) mortality (RR, 0.77; 95% CI, 0.65-0.92; P = 0.003) between the OLS group and control group, with no substantial heterogeneity. There was no significant difference in ventilator-free days at 28-day (mean difference [MD]; 3.32 d; 95% CI, -0.49 to 7.12; P = 0.09) and ICU length of stay (MD; 1.60 d; 95% CI, -2.99 to 6.20; P = 0.49) between OLS group and control group.
CONCLUSIONS: Results from this systematic review and meta-analysis suggest that OLS during mechanical ventilation significantly reduces mortality among patients with ARDS.
参考来源
- Lu J, Wang X, Chen M, et al. An Open Lung Strategy in the Management of Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis. Shock. 2017. PMID: 28125527. doi:10.1097/SHK.0000000000000822
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。